Sort
15,842 grants matching “pancreatic cancer”
A Patient-Centric Approach to Advance Functional Precision Oncology
$1,060,954Christopher J Kemp · Fred Hutchinson Cancer Center · U01 · FY2025 · CA
Novel MAP Kinase Pathway Inhibitors to Treat Pancreatic Ductal AdenoCarcinoma
$1,060,799Peter Qinhua Huang · Zeno Management, Inc · R44 · FY2018 · CA
UCLA Center for Excellence in Pancreatic Diseases
$1,060,276Vay Liang W. Go · University Of California Los Angeles · P01 · FY2011 · AT
Pathways that Suppress or Accelerate Premalignant Progression of Squamous Cancer
$1,057,469Stuart H. Yuspa · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Integrative Molecular Profiling of Human Pancreatic Cancer
$1,057,062Syed Perwez Hussain · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Role of Immune and Inflammation Mediators in Progression of Pancreatic Cancer
$1,057,062Syed Perwez Hussain · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Preclinical drug development in pancreas cancer
$1,056,492Udo Rudloff · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
The MYC Transcription Factor Network and the Path to Cancer
$1,056,000Robert Neil Eisenman · Fred Hutchinson Cancer Research Center · R35 · FY2020 · CA
DNA Topoisomerases as nuclear and mitochondrial targets of Anticancer Drugs
$1,055,681Yves Pommier · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Prevention & Metastasis: Final Frontiers in Colon Cancer
$1,051,364Robert J Coffey · Vanderbilt University · U01 · FY2008 · CA
IGF::OT::IGF CORE INFRASTURCTURE SUPPORT FOR SURVEILLANCE, EPIDEMIOLOGY AND END RESULTS (SEER)PERIOD OF PERFORMANCE: 05/01/2015 TO 04/30/2016
$1,048,092Antoinette Stroup · Rbhs -Cancer Institute Of New Jersey · N01 · FY2015 · CA
Post-transcriptional control of Proliferation, Stress Response & Carcinogenesis
$1,046,405Myriam Gorospe · National Institute On Aging · ZIA · FY2016 · AG
AC-225 Imaging R01 Transfer
$1,043,907Javier Caravaca · University Of Calif-Lawrenc Berkeley Lab · R01 · FY2024 · EB
Suppressors of kRAS Activity Discovered Using a Fruit Fly-based In-vivo Screen
$1,043,722William A. Garland · Tosk, Inc. · R44 · FY2017 · CA
The Role of Cripto in the Pathogenesis of Breast and Colon Cancer
$1,042,793David Salomon · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
SPORE in Pancreatic Cancer
$1,042,511James L Abbruzzese · University Of Tx Md Anderson Can Ctr · P20 · FY2007 · CA
The TGFÃÂÃÂÃÂÃÂÃÂÃÂÃÂò Signaling Pathway in Development and Cancer
$1,040,760Joan Massague · Sloan-Kettering Inst Can Research · R35 · FY2022 · CA
The TGFÃÂÃÂÃÂÃÂÃÂÃÂÃÂò Signaling Pathway in Development and Cancer
$1,040,760Joan Massague · Sloan-Kettering Inst Can Research · R35 · FY2023 · CA
Targeted disruption the enzymes of O-GlcNAc cycling: Animal models of Disease
$1,038,959John A. Hanover · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2016 · DK
Colorectal Cancer (CRC) Prevention by Urolithin A in Rodent CRC models
$1,038,958Margie L. Clapper · Research Inst Of Fox Chase Can Ctr · N01 · FY2023 · CA
Stromal modulation of pancreatic cancer malignant cell state and therapeutic sensitivity
$1,037,023William C Hahn · Dana-Farber Cancer Inst · U01 · FY2022 · CA
Stromal modulation of pancreatic cancer malignant cell state and therapeutic sensitivity
$1,037,023William C Hahn · Dana-Farber Cancer Inst · U01 · FY2025 · CA
Stromal modulation of pancreatic cancer malignant cell state and therapeutic sensitivity
$1,037,023William C Hahn · Dana-Farber Cancer Inst · U01 · FY2023 · CA
Cellular In vivo Imaging
$1,035,876Peter L. Choyke · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Molecular Response and Imaging-based Combination Strategies for Optimal PDT
$1,035,201Tayyaba Hasan · Massachusetts General Hospital · P01 · FY2020 · CA